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Abstract
Some researchers have compared neuropsychological performance in schizophrenia groups with and without presumed IQ
decline. Inherent in this approach is an assumption that group differences are due to different IQ trajectories (stable vs. declining),
but neuropsychological differences could be a function of current IQ regardless of the presence or absence of previous IQ decline.
We examined this issue in 93 normal controls and in 80 patients classified as having preserved (27.5%), deteriorated (50%), or
compromised (22.5%) intellect based on IQ and reading recognition-IQ difference scores. We also examined group differences in
verbal and performance IQ. Deteriorated patients had the largest verbal performance-IQ differences. They were more
neuropsychologically impaired than the preserved group (average effect size=0.43), but deteriorated patients also had significantly
lower current IQs. When subgroups of preserved and deteriorated patients with equivalent current IQs were compared,
neuropsychological differences were essentially eliminated (average effect size=0.10); however, both groups were significantly
more impaired than controls with similar IQs. Neuropsychological impairment, even in patients with apparently preserved IQ, is
consistent with a prefrontal-dysexecutive syndrome. Overall, these results strongly suggest that differences in current
neuropsychological function in schizophrenia are attributable primarily to current IQ instead of to IQ trajectory over time.
© 2008 Published by Elsevier Ireland Ltd.
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1. Introduction
Elucidating the course of intellectual–cognitive
function and discerning meaningful neurocognitive
subgroups or subtypes are important components for
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understanding the nature of neurocognitive impairment
in schizophrenia. By developing a strategy in which
schizophrenia subgroups were defined on the basis of
both current IQ and the presence/absence of putative IQ
decline over time, Weickert et al. (2000) essentially
integrated these two issues. Badcock et al. (2005)
subsequently applied the same strategy to an indepen-
dent sample of schizophrenia patients.
These investigators have compared current neuropsy-
chological function among these schizophrenia sub-
groups. Inherent in this approach is an assumption that
current neuropsychological performance differs as a
function of putative IQ trajectory (stable vs. declining
over time); otherwise, therewould be little point in defining
groups in this manner. An alternative— and perhaps more
parsimonious — explanation ought to be tested, namely,
that the group differences are attributable primarily to
current IQ regardless of IQ trajectory over time. Even if the
latter explanation were supported, it would not imply that
IQ decline in schizophrenia is necessarily unimportant. If
we are to shed light on the relevance of IQ decline to the
cognitive basis of schizophrenia, however, it is important to
clarify what is and is not predicted by IQ decline. The
primary goal of the present study was to examine the issue
of the inferred effects on neuropsychological performance
of IQ decline over time in schizophrenia in a cross-sectional
study using the approach developed by Weickert et al.
(2000).
There is consistent evidence for lower childhood and
adolescent intellectual function measured at a single time
point in individuals who later develop schizophrenia
compared with their peers (Jones et al., 1994; David
et al., 1997; Cannon et al., 2000b; Erlenmeyer-Kimling
et al., 2000; Cannon et al., 2002a). Furthermore, there is
evidence of decline over time before the onset of
psychosis in individuals who later develop schizophre-
nia-related disorders (Jones et al., 1994; David et al.,
1997; Kremen et al., 1998). Longitudinal studies
comparing pre- and post-morbid IQ are rare. Three
such studies reviewed by Heaton and Drexler (1987) did
indicate declines, but a study by Russell et al. (1997) did
not. Russell et al. (1997) studied patients with relatively
low IQwho had available premorbid IQ scores as a result
of being referred for treatment in childhood; these results
might thus reflect a select group of patients that
experienced a good deal of lifelong impairment or that
had experienced declines very early in life. In a lon-
gitudinal study of a community sample, Seidman et al.
(2006) found premorbid IQ deficits in those who
developed schizophrenia as well as a post-morbid
decline of about 10 points about 28 years later; however,
it is not known when the decline took place.
Despite some evidence of post-onset decline, there
does not appear to be support for the Kraepelinian
notion of progressive deterioration; indeed, with the
exception of some very persistently treatment-resistant
patients (Harvey et al., 1999), there appears to be
relative stability or even slight improvements in IQ and
other neuropsychological functions after an initial post-
onset decline (Kurtz, 2005).
The twin method, in the form of the co-twin-control
design, provides a powerful addition to these studies of
unrelated individuals because the unaffected co-twin
serves as an ideal approximation of how the ill twin
would perform if not impaired by the illness. Twin data
support the existence of premorbid intellectual deficits in
schizophrenia but are also consistent with the presence of
further post-onset decline. In two twin studies, twins were
tested before the onset of psychosis. Reichenberg et al.
(2000) and Kremen et al. (2006) examined twin pairs
discordant for psychosis, but did not find statistically
significant within-pair premorbid cognitive ability differ-
ences; however, Kremen et al. (2006) did find significant
differences within pairs discordant for schizophrenia
specifically. In twin pairs discordant for schizophrenia
who were tested long after the onset of illness,
nonpsychotic twins did not differ from their ill co-twins
on the Wide Range Achievement Test-Revised (WRAT-
R; Jastak and Wilkinson, 1984) — an estimate of
premorbid ability — but nonpsychotic twins had about
a 10-point higher IQ than their co-twins with schizophre-
nia (Goldberg et al., 1990). In another twin study of post-
morbid functioning (Cannon et al., 2000c), IQ differences
between twins with schizophrenia and their nonpsychotic
co-twins were also about 10 points. These post-morbid IQ
differences were greater than the premorbid cognitive
ability difference in the Kremen et al. (2006) study. Taken
together, the twin data suggest both premorbid cognitive
deficits and post-onset cognitive decline.
1.1. IQ versus neuropsychological function
Given that IQ is a composite measure reflecting a
subset of neuropsychological ability, a distinction
between intellect and neurocognitive function is some-
what arbitrary. On the other hand, there is a long
tradition in which IQ is treated as an index of general
intellectual ability (g) to distinguish it from other neu-
ropsychological functions because, in general, perfor-
mance on other neuropsychological tests will tend to be
higher when g is higher. Therefore, the distinction still
does have some utility.
Multiple neuropsychological impairments have been
observed in schizophrenia in the context of roughly
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average or low-average general intellectual functioning
(Seidman, 1983; Goldstein, 1986; Braff et al., 1991;
Elliot et al., 1998). Even when schizophrenia patients
and normal comparison subjects are equated for current
IQ levels (Kremen et al., 2001) or when IQ is controlled
for statistically (Seidman et al., 2002), patients still
perform substantially more poorly on a variety of other
neuropsychological measures. Despite the apparent
ubiquity of neuropsychological impairment in schizo-
phrenia, roughly a quarter of schizophrenia patients
display apparently normal neuropsychological perfor-
mance (Golden et al., 1982; Silverstein and Zerwic,
1985; Palmer et al., 1997; Kremen et al., 2000; Weickert
et al., 2000; Allen et al., 2003). However, even this
subgroup may have experienced decline from premor-
bid levels of cognitive ability (Kremen et al., 2000).
1.2. IQ trajectories
In a cross-sectional study, Weickert et al. (2000)
measured presumed differences between premorbid and
current IQ using the reading subtest of the Wide Range
Achievement Test-Revised (WRAT-R; Jastak and Wilk-
inson, 1984) as an index of premorbid intellectual ability.
Based on the idea that individuals with schizophrenia
would differ depending on whether or not they had
experienced a decline in IQ, they divided schizophrenia
patients into three groups: stable and average IQ
(preserved); stable and below average IQ (compromised);
and IQ decline from premorbid levels (deteriorated). The
preserved group had the best neuropsychological perfor-
mance, but even this group manifested some neuropsy-
chological deficits in executive function and possibly in
sustained attention–vigilance. Not surprisingly, neuro-
psychological impairment was most severe and wide-
spread in the compromised group, with the deteriorated
group falling between the preserved and compromised
groups. Badcock et al. (2005) utilized the same means
of classification and generally found better perfor-
mance in the preserved group, but nonsignificant
differences between the deteriorated and compromised
groups. However, none of the groups in the Badcock et
al. study differed in processing speed as measured by
inspection time. In the former study, current IQ scores
were highest in the preserved group, in between in the
deteriorated group, and lowest in the compromised
group. In the latter study, current IQs were highest in
the preserved group, but they were not different in the
deteriorated versus the compromised group. This
pattern suggests that the difference in most areas of
neuropsychological performance among the groups
may be more a function of differences in current IQ
than of differences in presumed IQ trajectories (i.e.,
stable vs. declining). In other words, IQ trajectory and
current IQ are confounded to the extent that the
deteriorated group differs from the others on current
IQ.
We addressed the following questions about schizo-
phrenia in the present study: 1) To what extent is current
neuropsychological performance associated with cur-
rent IQ versus presumed decline in IQ from premorbid
levels? 2) To what extent are neuropsychological
deficits present when IQ is presumed to be preserved?
3) Are putative IQ declines accounted for equally by
verbal IQ (VIQ) and performance IQ (PIQ)?
2. Methods
Portions of the study methods have been described in
detail elsewhere (Faraone et al., 1995; Kremen et al.,
1995, 2000; Seidman et al., 2002).
2.1. Participants
Patients were recruited from three Boston area
hospitals. They were required to have a DSM-III-R
diagnosis of schizophrenia (American Psychiatric Asso-
ciation, 1987). Control participants were recruited from
nonprofessional hospital staff and advertisements in the
community. Controls were required to have no family
history of psychosis and no psychopathology (although
history of substance use disorders was permitted).
Otherwise, study inclusion/exclusion criteria were the
same for patients and control participants. These criteria
were as follows: age 18 or older; English as the primary
language; at least 8 years of formal education; no
neurologic disease or damage; no current substance abuse
(within the past 6 months); no history of head injury with
loss of consciousness greater than 5 min or with
documented neurocognitive sequelae; no mental retarda-
tion (IQb70); and no medical illnesses that may be
associated with significant neurocognitive impairment.
Most of the participants in the present study were
also the subject of prior reports (Fucetola et al., 2000;
Kremen et al., 2000; Seidman et al., 2002). There were
93 controls and 80 patients. All participants gave
informed consent and were paid to participate.
2.2. Procedures and instruments
2.2.1. Assessment of psychopathology
Consensus lifetime DSM-III-R diagnoses for patients
were determined on the basis of interviews conductedwith
the Schedule for Affective Disorders and Schizophrenia
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(SADS) (Endicott and Spitzer, 1978), medical record
reviews, and consultation with treating clinicians. In place
of the interview, controls were screened for current
psychopathology with a short form of the Minnesota
Multiphasic Personality Inventory (Vincent et al., 1984)
and were excluded if any clinical or validity T-scale,
except Masculinity–Femininity, was above 70.
2.2.2. Neuropsychological assessment
We administered a battery of tests assessing multiple
domains of cognitive function (Table 1). Patients were
tested when judged by clinical staff who were familiar
with them to be relatively stable clinically (i.e., at their
clinical baseline).
2.2.3. Current IQ
Only 61 patients and 25 controls were administered all
11 Wechsler Adult Intelligence Scale-Revised (WAIS-R)
(Wechsler, 1981) subtests, but all participants in the
present study had age-scaled scores for the Vocabulary,
Digit Span, Block Design, and Digit Symbol subtests. To
create a current IQ score, we regressed full scale IQ (FSIQ)
scores on the age-scaled scores for these four subtests in
the subgroup of participants who had undergone the
complete WAIS-R. Separate regression analyses were
performed for patients and controls because different
subtests might have different weightings in these two
groups. Linear regressions provided excellent estimates of
FSIQ (R2=0.86 for patients,F(4,56)=85.09,R2=0.91 for
controls, F(4,20) =48.33, Psb0.0001). Regression
weights from each analysis were used to generate FSIQ
scores for patients and controls, respectively. We
performed parallel analyses with Verbal (Vocabulary,
Digit Span) and Performance (Block Design, Digit
Symbol) subtests separately to generate VIQ and PIQ
scores, respectively (0.79bR2b0.86).
2.2.4. Expected/premorbid IQ
As in the study of Weickert et al. (2000), expected or
premorbid IQ was based on the standard score of the
WRAT-R Reading subtest. Reading scores are com-
monly similar in patients and controls, even though IQ is
almost always significantly lower in patients (Dalby and
Williams, 1986; Goldberg et al., 1995; Kremen et al.,
1996). Based on these considerations, premorbid to
post-onset IQ decline was inferred on the basis of
WRATR-Reading-FSIQ differences. Given the fact that
many schizophrenia patients have neurodevelopmental
impairments prior to onset of psychosis (Fish et al.,
1965; Feinberg, 1982; Weinberger, 1987; Seidman,
1990) and manifest cognitive impairments prior to onset
(Zammit et al., 2004; Kremen et al., 2006; Seidman et
al., 2006), the notion of a premorbid period may be
imprecise. We use the term “premorbid IQ” as a kind of
shorthand; it is perhaps most accurate to think of
WRAT-R Reading as an estimate of general intellectual
potential had a given individual not been predisposed to
develop schizophrenia.
Table 1
Neuropsychological test battery
Neuropsychological
function
Tests and scores
Verbal fluency FAS Test (Benton, 1967) Phonemic=average number of words beginning with F, A, S. Semantic=number of words
belonging to the category “animals”
General visual–spatial
ability
Judgment of Line Orientation (Benton et al., 1983)⁎ Hooper Visual Organization Test (Hooper, 1983)⁎ Rey-Osterrieth
Complex Figure copy (Rey, 1941)
Verbal declarative
memory a
Wechsler Memory Scale— Form 1 (WMS) (Wechsler, 1945) or Wechsler Memory Scale— Revised (WMS-R) (Wechsler,
1987) logical memories % recalled on immediate and delayed recall, ⁎ and savings score (immediate/delayed×100)
Abstraction–Executive Wisconsin Card Sorting Test perseverations and categories (Grant and Berg, 1948; Heaton, 1981) ⁎Visual–verbal test total
misses (Feldman and Drasgow, 1981)⁎
Executive motor Manual Position Sequencing total correct (Luria, 1980)⁎ Graphic Sequencing total score and perseverations (Luria, 1980)⁎
Perceptual–motor
speed
Trail Making Test Parts A and B time in seconds (War Department, 1944)⁎
Mental control–
encoding
Wide Range Achievement Test-Revised Arithmetic (Jastak and Wilkinson, 1984) ⁎
Sustained attention–
vigilance
Auditory Continuous Performance Test correct hits (Weintraub and Mesulam, 1985) ⁎ Dichotic Listening Test digits
detected (regardless of ear of report accuracy) and digits correct (based on ear of report) (Kimura, 1967)⁎
Standardized composite scores were created for all functions except Verbal Fluency (see text for details).
Asterisks following test scores indicate that those scores were included in the composite scores.
a The WMS-R was published after the study began and the decision was made to switch from the WMS to the WMS-R. Consequently, some
participants were given the older version and some were given the newer version. We calculated each participant's score as a percentage of the
maximum possible score because the raw score totals of the logical memories stories differs on the two test versions.
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2.2.5. Definition of schizophrenia subgroups
Patients were assigned to one of the following three
groups according to the classification used by Weickert
et al. (2000): 1) The preserved group included patients
with average (normal range) premorbid IQ based on
WRAT-R Reading without evidence of decline (Reading
z90 and Reading-IQ difference b10). 2) The compro-
mised group included patients with below average
premorbid IQ without evidence of decline (Reading b90
and Reading-IQ difference b10). 3) The deteriorated
group included patients with evidence of decline from
premorbid level of functioning (Reading-IQ difference
z10, regardless of absolute score on either measure).
Dichotomizing groups in terms of IQ stability (stable
vs. declining) and premorbid IQ level (average vs. below
average) yielded four potential cells. In our study, as in
the other studies using this classification, what would
have been a declining-below average group and a
declining-average group were combined. Only two of
the 40 deteriorated patients in the present study had
premorbid IQs below 90. Consequently, we compared
three rather than four patient groups. Given that the
premorbid IQ of this deteriorated group was solidly
average in each of the studies using this approach, it may
be that very few schizophrenia patients who start with
below average IQ also manifest an IQ decline.
Alternatively, floor effects (e.g., regression to the
mean) might make it difficult to detect such patients.
We did not include controls in these subgroup
classifications because our interest was in comparing
putative IQ trajectories in schizophrenia. Moreover,
only 6% of the controls would have been classified as
deteriorated, suggesting that large Reading-IQ discre-
pancies are rare in 10 psychiatrically healthy indivi-
duals. This percentage was highly significantly different
from the 50% of patients in the deteriorated group
(χ2 =41.78, df=1, Pb0.0001).
2.3. Statistical analysis
Continuous variables were compared with analysis of
variance (ANOVA). Significant ANOVAs were followed
up with pairwise comparisons based on Fisher's least
significant difference (LSD) test. As expected, current IQ
was significantly different between the deteriorated and
preserved groups (see Section 3). Current IQ was also
significantly different between the control and the
deteriorated groups, although each of these was close to
the general population average of 100. To examine
differences specifically on the basis of current IQ — as
opposed to IQ trajectory—we performed a second set of
analyses in which there were equivalent current IQs in
these three groups (referred to as FSIQ-matched groups).
To achieve this equivalence, we removed controls with
the highest IQs and deteriorated patients with the lowest
IQs until group means were equivalent to those of the
preserved patients. Patients were omitted from the
deteriorated rather than the preserved group because the
former was a larger group than the latter. Participants
were removed in descending or ascending order of IQ
without knowledge of any of their other data. This
process ensured unbiased selection for these analyses. It
also resulted in removal of the two deteriorated patients
with below average premorbid IQs.
To provide an additional comparison with our
previous work and to account for the potential influence
of some demographic variables, the subsamples in which
the three groups (control, preserved, deteriorated) were
equated for current IQ were also compared on seven
composite neuropsychological function scores that we
have reported on in previous work (Kremen et al., 2001).
These include the functions shown in Table 1, except for
verbal fluency. Function scores were the mean of
standardized residual scores for tests comprising that
function; the direction of some individual scores was
changed so that higher scores always reflected better
performance. Regression equations based on controls
only were used to predict neuropsychological test scores,
given an individual's age, sex, and parental education.
Regression weights for these variables, derived on the
basis of the control group only, were then used to
generate predicted scores for both patients and controls.
Standardized residual (observed minus predicted) scores
were used in these analyses.
To account for potentially misleading results derived
from ANOVAs with unequal sample sizes, we used
general linear models for unbalanced designs in which
adjusted (least squares) means are tested (Freund et al.,
1986). Sample sizes also vary for some analyses because
data for approximately 3% of the measures were missing
(see Tables). In order to facilitate direct comparisons of
neuropsychological results based on different sample
sizes, effect sizes were computed by means of Cohen's
(1988) d. Categorical variables were compared with χ2
statistics. All tests were two-tailed.
3. Results
3.1. Entire sample
3.1.1. Demographic and clinical characteristics
Slightly more than a quarter (27.5%) of the patients
were in the preserved group, half were in the deteriorated
group (50%), and nearly a quarter (22.5%) were in the
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compromised group. As shown in Table 2, current IQs
were significantly different among all groups. The lower
FSIQ of the deteriorated group compared with controls
or the preserved group was accounted for primarily by
PIQ differences. Premorbid IQs, based on WRAT-R
Reading, were significantly different among all groups
except for controls and preserved group patients. Read-
ing scores were highest in deteriorated patients and
lowest in compromised patients. Although within-group
differences were, by definition, less than 10 points,
Reading scores appeared to be lower than FSIQ scores in
the compromised group. The groups were not signifi-
cantly different in age or parental education. There were
some significant differences in education, but deterio-
rated and preserved groups did not differ. Antipsychotic
medication dosage, length of illness, and symptom
ratings did not differ among patient groups, but age of
first psychiatric hospitalization was significantly earlier
in the compromised group than in the other patient
groups.
3.1.2. Neuropsychological performance
Overall group differences were highly significant for
all neuropsychological measures (see Table 3). Pairwise
comparisons revealed that controls performed significant-
ly better than each of the patient groups on almost all
neuropsychological measures. The exception was that
controls and preserved patients did not differ significantly
in verbal fluency (semantic, phonemic), visual–spatial
ability (Line Orientation, Rey-Osterrieth copy), verbal
Table 2
Demographic and clinical characteristics in normal controls and in schizophrenia patients with and without presumed IQ decline (entire sample)
Schizophrenia patients
Normal controls
(n=93)
Preserved
(n=22)
Deteriorated
(n=40)
Compromised
(n=18)
Characteristic Mean (S.D.) Mean (S.D.) Mean (S.D.) Mean (S.D.) F-test Pairwise
comparisons a
Effect sizes
(2 vs. 3) b
Current FSIQ 105.1 (12.8) 98.4 (8.9) 90.9 (9.2) 81.9 (7.5) 0.0001 1N2N3N4 0.82
Current VIQ 105.6 (13.2) 100.6 (12.3) 97.2 (10.5) 84.0 (7.4) 0.0001 1N3N4; 2N4 0.31
Current PIQ 104.0 (11.7) 94.8 (7.3) 84.3 (8.3) 81.3 (7.9) 0.0001 1N2N3,4 1.33
VIQ–PIQ difference 1.5 (13.1) 5.8 (12.2) 12.2 (12.9) 9.4 (2.7) 0.0001 3N2,4,1 −0.50
Premorbid IQ c 102.1 (13.4) 103.2 (8.0) 109.7 (9.7) 75.7 (9.6) 0.0001 3N2,1N4 −0.71
Age 42.2 (15.3) 44.0 (12.8) 45.8 (11.4) 37.2 (11.0) 0.17 0.15
Education 13.5 (2.5) 12.4 (2.0) 12.6 (2.3) 10.3 (1.5) 0.0001 1N3,2N4 −0.09
Parental education d 10.9 (2.2) 12.0 (3.0) 11.7 (3.0) 10.9 (2.3) 0.17 0.10
Age of first psychiatric
hospitalization d
– 25.9 (6.0) 25.3 (6.8) 19.9 (4.5) 0.005 2,3N4 0.09
Length of illness
(yrs.) d
– 18.6 (11.2) 20.9 (11.0) 18.7 (12.4) 0.69 0.21
Antipsychotic
medication d, e
– 539.5 (391.5) 536.5 (484.6) 777.8 (768.9) 0.27 0.01
Symptoms d, f
Negative – 1.8 (1.1) 1.7 (0.9) 2.0 (1.4) 0.71 – −0.10
Reality distortion – 1.8 (1.6) 2.3 (1.3) 2.1 (1.7) 0.60 – 0.36
Disorganization – 1.1 (1.0) 1.3 (1.1) 1.3 (0.8) 0.79 – 0.18
n (%) n (%) n (%) n (%) χ2 – –
Sex (females) g 50 (54.4) 8 (36.4) 8 (20.0) 2 (11.1) 0.0001 – –
FSIQ=Full Scale IQ; VIQ=Verbal IQ; PIQ=Performance IQ.
a 1=normal controls; 2=preserved; 3=deteriorated; 4=compromised; commas indicate that groups are not significantly different from one
another.
b Effect sizes presented for groups 2 versus 3 only; positive values indicate that group 2 has the higher or less pathological score; negative values
indicate that group 3 has the higher or less pathological score.
c Based on Wide Range Achievement Test-Revised Reading subtest (Jastak and Wilkinson, 1984).
d Ns vary due to missing data.
e Dosage in mg. Chlorpromazine equivalents.
f Based on the Scale for the Assessment of Negative Symptoms (SANS) (Andreasen, 1983) and the Scale for the Assessment of Positive
Symptoms (SAPS) (Andreasen, 1984); inattention subscale was omitted from the negative symptom dimension because of its redundancy with
cognitive function.
g Mantel–Haenszel χ2=20.60, df=1, Pb0.0001 indicates significant trend across groups; for patients only, χ2=3.91, df=2, P=0.15.
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memory (savings), mental control–encoding (Arithme-
tic), and attention–vigilance (dichotic listening).
The preserved patient group performed significantly
better than the deteriorated or compromised group in
verbal fluency (semantic, phonemic), visual–spatial
ability (Line Orientation, Rey-Osterrieth copy), verbal
memory (Logical Memories delayed, savings score), and
perceptual–motor speed (Trail Making Test A and B).
The performance of the deteriorated groupwas, in turn,
significantly better than that of the compromised group in
verbal fluency (semantic), visual–spatial ability (Line
Orientation), abstraction–executive (WCST categories),
verbal memory (Logical Memories immediate), mental
control–encoding (Arithmetic), and executive motor
(graphic sequencing, manual position sequencing).
Some of these comparisons might be misleading owing
to differences in sample sizes across groups. For example,
the preserved group achieved slightly more WCST
categories than the deteriorated group; however, the
deteriorated group, but not the preserved group, was
significantly better than the compromised group on
WCST categories. This paradoxical result occurred
because of the greater power afforded by the larger
sample size of the deteriorated group compared with the
Table 3
Neuropsychological performance in normal controls and in schizophrenia patients with and without presumed IQ decline (entire sample)
Schizophrenia patients
Normal controls
(n=93)
Preserved
(n=22)
Deteriorated
(n=40)
Compromised
(n=18)
Neuropsychological function/
measure
Mean (S.D.) Mean (S.D.) Mean (S.D.) Mean (S.D.) F-test Pairwise
comparisons a
Effect sizes
(2 vs. 3) b
Verbal fluency
Phonemic c 13.6 (3.8) 12.0 (4.5) 10.1 (3.9) 8.4 (3.1) 0.0001 1,2N3,4 0.46
Semantic c 18.9 (4.8) 16.9 (5.2) 14.0 (3.9) 11.3 (4.4) 0.0001 1,2N3N4 0.66
Visual–spatial
Line orientation c 24.4 (4.3) 25.8 (3.8) 23.0 (5.4) 19.4 (6.2) 0.0007 2N3N4; 1N4 0.58
Hooper VOTc 26.2 (2.7) 23.8 (4.2) 22.0 (4.9) 22.0 (7.0) 0.0001 1N2,3,4 0.39
Rey-Osterrieth copy c 33.1 (2.9) 31.4 (4.5) 27.8 (6.9) 26.5 (6.5) 0.0001 1,2N3,4 0.59
Executive–abstraction
WCST categories c 5.3 (1.5) 3.6 (2.6) 2.5 (2.2) 2.4 (2.4) 0.0001 1N2,3,4; 2N3 0.48
WCST perseverations c 9.8 (11.4) 36.0 (43.7) 46.1 (38.1) 58.2 (50.1) 0.0001 4N2N1; 3N1 0.25
Visual–verbal test c 13.7 (6.5) 26.2 (12.2) 29.2 (13.1) 32.9 (15.5) 0.0001 4,3,2N1, 4N2 0.23
Verbal memory
Logical memories
immediate
59.2 (12.0) 45.4 (19.2) 38.4 (18.5) 29.3 (17.3) 0.0001 1 N2,3,4; 2 N4;
3N4
0.37
Logical memories
delayed
51.2 (13.9) 38.0 (17.5) 28.6 (17.2) 20.8 (15.2) 0.0001 1N2N3,4 0.54
Savings score 85.8 (13.5) 82.1 (20.4) 69.2 (24.1) 69.7 (29.3) 0.0001 1,2N3,4 0.56
Mental control–encoding
WRAT-R arithmetic c 96.6 (15.7) 95.6 (12.8) 90.7 (13.6) 75.0 (11.7) 0.0001 1N3,4; 2N4, 3N4 0.37
Perceptual–motor
Trails A c 28.7 (12.4) 39.7 (14.2) 55.6 (29.9) 60.0 (45.9) 0.0001 4,3N2N1 0.66
Trails B c 69.6 (33.8) 109.3 (58.4) 157.8 (106.4) 161.9 (97.3) 0.0001 4,3N2N1 0.54
Executive–motor
Manual position 23.8 (3.9) 19.2 (8.1) 16.1 (9.0) 17.0 (8.4) 0.0001 1N2,4,3 0.36
Sequencing c
Graphic sequencing c 0.8 (0.8) 1.3 (1.1) 1.2 (0.9) 1.7 (1.1) 0.0009 4N3,1; 2N1 −0.10
Sustained attention–
vigilance
CPTc 29.0 (1.3) 26.6 (3.5) 25.1 (5.4) 24.2 (4.8) 0.0001 1N2,3,4; 2N4 0.31
Dichotic digits correct c 205.4 (40.7) 191.8 (44.6) 164.9 (62.7) 155.7 (45.6) 0.0001 1N3,4; 2N4 0.48
Dichotic digits detected c 231.6 (37.3) 226.3 (30.7) 200.8 (54.5) 205.0 (24.3) 0.0002 1N4,3; 2N3 0.56
a 1=normal controls; 2=preserved; 3=deteriorated; 4=compromised; commas indicate that groups are not significantly different from one
another.
b Effect sizes presented for groups 2 versus 3 only; positive values indicate that group 2 has the higher or less pathological score; negative values
indicate that group 3 has the higher or less pathological score.
c Ns vary due to missing data.
187W.S. Kremen et al. / Psychiatry Research 158 (2008) 181–194
preserved group. Indeed, the effect sizes for these two
comparisons were almost identical. Because the differ-
ences of greatest interest in the present study are those
between the preserved and deteriorated groups, Tables 2–
5 show effect sizes (d) for those comparisons. The average
d in Table 3 is 0.43, indicating a medium effect size with
better performance in the preserved group than in the
compromised group. These effects tended to be fairly
consistent across different neurocognitive functions.
3.2. FSIQ-matched groups
This section refers to analyses comparing groups in
which controls, preserved patients, and deteriorated
patients were matched for group mean current IQ (FSIQ).
3.2.1. Demographic and clinical characteristics
Table 4 shows that the aforementioned groups were
now well matched on FSIQ. As in the full sample, the
deteriorated group had a significantly greater VIQ-PIQ
difference than the other groups. Owing to the way in
which the groups were defined, premorbid IQ was now
substantially higher in the deteriorated group than in any
of the other groups, with a very large d of 1.72 for the
comparison with preserved patients. There were no
other substantial changes with regard to group differ-
ences in other demographic or clinical characteristics.
3.2.2. Neuropsychological performance
Almost all of the overall group differences were
again highly significant for the neuropsychological
Table 4
Demographic and clinical characteristics in normal controls and in schizophrenia patients with and without presumed IQ decline (control, preserved,
and deteriorated groups equated for current IQ)
Schizophrenia patients
Normal controls
(n=66)
Preserved
(n=22)
Deteriorated
(n=21)
Compromised
(n=18)
Characteristic Mean (S.D.) Mean (S.D.) Mean (S.D.) Mean (S.D.) F-test Pairwise
comparisons a
Effect sizes
(2 vs. 3) b
Current IQ 98.4 (7.6) 98.4 (8.9) 97.6 (5.7) 81.9 (7.5) 0.0001 1,2,3N4 0.10
Current VIQ 99.1 (8.1) 100.6 (12.3) 103.8 (7.6) 84.0 (7.4) 0.0001 3N1,4; 2N4 −0.32
Current PIQ 100.0 (9.4) 94.8 (7.3) 89.6 (7.3) 81.3 (7.9) 0.0001 1N2,3N4 0.71
VIQ–PIQ difference −0.9 (11.5) 5.8 (12.2) 14.2 (11.0) 9.4 (2.7) 0.0001 3N2,4,1; 2N1 −0.72
Premorbid IQ c 97.3 (12.4) 103.2 (8.0) 114.9 (5.5) 75.7 (9.6) 0.0001 3N2N1N4 −1.72
Age 41.2 (14.9) 44.0 (12.8) 47.0 (11.8) 37.2 (11.0) 0.13 0.24
Education 13.0 (2.4) 12.4 (2.0) 13.6 (2.0) 10.3 (1.5) 0.0001 3,1,2N4 −0.60
Parental education d 10.7 (2.3) 12.0 (3.0) 12.0 (2.9) 10.9 (2.3) 0.08 0.00
Age of first psychiatric
hospitalization d, e
25.9 (6.0) 27.1 (7.9) 19.9 (4.5) 0.003 3,2N4 −0.17
Length of illness
(yrs.) d
18.6 (11.2) 20.4 (12.6) 18.7 (12.4) 0.87 – 0.15
Antipsychotic
medication d, e
– 539.5 (391.5) 540.5 (489.0) 777.8 (768.9) 0.34 – 0.002
Symptoms d, f
Negative – 1.8 (1.1) 1.6 (1.0) 2.0 (1.4) 0.67 −0.17
Reality distortion – 1.8 (1.6) 2.3 (1.2) 2.1 (1.7) 0.66 – 0.36
Disorganization – 1.1 (1.0) 1.2 (1.1) 1.3 (0.8) 0.88 – 0.09
n (%) n (%) n (%) n (%) χ2 – –
Sex (females) g 35 (53.0) 8 (36.4) 5 (23.8) 2 (11.1) 0.004 – –
FSIQ=Full Scale IQ; VIQ=Verbal IQ; PIQ=Performance IQ.
a 1=normal controls; 2=stable–below-average; 3=IQ-decline; 4=stable–below-average; commas indicate that groups are not significantly
different from one another.
b Effect sizes presented for groups 2 versus 3 only; positive value indicates that group 2 has the higher or less pathological score; negative value
indicates that group 3 has the higher or less pathological score.
c Based on Wide Range Achievement Test-Revised Reading subtest (Jastak and Wilkinson, 1984).
d Ns vary due to missing data.
e Dosage in mg. Chlorpromazine equivalents.
f Based on the Scale for the Assessment of Negative Symptoms (SANS) (Andreasen, 1983) and the Scale for the Assessment of Positive
Symptoms (SAPS) (Andreasen, 1984); inattention subscale was omitted from the negative symptom dimension because of its redundancy with
cognitive function.
g Mantel–Haenszel χ2=13.23, df=1, Pb0.0003 indicates significant trend across groups; for patients only, χ2=3.42, df=2, P=0.19.
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measures (see Table 5). In contrast to the full sample
results, pairwise comparisons revealed only a single
significant difference between the preserved and
deteriorated groups. This difference was for Graphic
Sequencing errors, but it was in the opposite direct-
ion of most of the comparisons in that the preserved
group had more errors than the deteriorated group.
The general lack of significant differences was not
due to the reduced sample sizes in these analyses. In
stark contrast to the full sample results, the average
effect size for these comparisons between the FSIQ-
equated preserved and deteriorated patients was only
0.10.
Analysis of the composite neuropsychological func-
tion scores (which were adjusted for age, sex, and
parental education) in the groups that were equated for
IQ resulted in highly significant overall differences for
each of the seven functions (all Psb0.0001; see Fig. 1).
Pairwise comparisons indicated that controls performed
significantly better than the preserved group on five
composite functions: abstraction–executive; verbal
memory; perceptual–motor speed; executive motor
ability; and sustained attention–vigilance. Controls
performed significantly better than the deteriorated
group on four of those five functions: all but executive
motor ability. There were no significant differences
Table 5
Neuropsychological performance in normal controls and in schizophrenia patients with and without presumed IQ decline (control, preserved, and
deteriorated groups equated for current IQ)
Schizophrenia patients
Normal controls
(n=66)
Preserved
(n=22)
Deteriorated
(n=21)
Compromised
(n=18)
Neuropsychological function/
measure
Mean (S.D.) Mean (S.D.) Mean (S.D.) Mean (S.D.) F-test Pairwise
comparisons a
Effect sizes
(2 vs. 3) b
Verbal fluency
Phonemic c 13.0 (3.5) 12.0 (4.5) 11.3 (3.9) 8.4 (3.1) 0.0002 1,2,3N4 0.17
Semantic c 18.1 (4.8) 16.9 (5.2) 16.1 (2.7) 11.3 (4.4) 0.0001 1,2,3N4 0.20
Visual–spatial
Line orientation c 23.4 (4.6) 25.8 (3.8) 24.4 (3.3) 19.4 (6.2) 0.002 2,3,1N4 0.39
Hooper VOTc 25.9 (2.7) 23.8 (4.2) 22.6 (4.7) 22.0 (7.0) 0.002 1N2,3,4 0.27
Rey-Osterrieth copy c 32.9 (2.9) 31.4 (4.5) 30.4 (4.7) 26.5 (6.5) 0.0001 1N3,4; 2,3N4 0.22
Executive–abstraction
WCST categories c 5.0 (1.7) 3.6 (2.6) 3.3 (2.3) 2.4 (2.4) 0.0001 1N2,3,4 0.12
WCST perseverations c 12.5 (12.4) 36.0 (43.7) 37.3 (36.0) 58.2 (50.1) 0.0001 4N3,2N1 0.03
Visual–verbal test c 14.9 (6.9) 26.2 (12.2) 22.7 (10.6) 32.9 (15.5) 0.0001 4,N2,3N1 −0.31
Verbal memory
Logical memories
immediate
57.2 (12.1) 45.4 (19.2) 46.4 (14.8) 29.3 (17.3) 0.0001 1N,3,2N4 −0.06
Logical memories delayed 48.8 (14.0) 38.0 (17.5) 36.3 (15.0) 20.8 (15.2) 0.0001 1N2,3N4 0.10
Savings 84.6 (14.4) 82.1 (20.4) 77.1 (16.8) 69.7 (29.3) 0.02 1,2N4 0.27
Mental control–encoding
WRAT-R arithmetic 94.2 (12.2) 95.6 (12.8) 97.4 (13.7) 75.0 (11.7) 0.0001 3,2,1N4 −0.14
Perceptual–motor
Trails A c 29.5 (13.2) 39.7 (14.2) 47.2 (16.6) 60.0 (45.9) 0.0001 4N2,1; 3N1 0.49
Trails B c 74.5 (37.5) 109.3 (58.4) 116.5 (58.2) 161.9 (97.3) 0.0001 4N3,2N1 0.12
Executive–motor
Manual position
sequencing c
23.6 (4.3) 19.2 (8.1) 18.8 (8.5) 17.0 (8.4) 0.0003 1N2,3,4 0.05
Graphic sequencing 0.9 (0.8) 1.3 (1.1) 0.7 (0.7) 1.7 (1.1) 0.002 4N1,3; 2N3; 3N4 −0.67
Sustained attention–vigilance
CPTc 29.1 (1.2) 26.6 (3.5) 25.8 (4.7) 24.2 (4.8) 0.0001 1N2,3,4; 2N4 0.20
Dichotic digits correct c 202.2 (38.9) 191.8 (44.6) 185.9 (54.5) 155.7 (45.6) 0.003 1N4; 2N4 0.12
Dichotic digits detected c 231.1 (35.1) 226.3 (30.7) 219.9 (48.2) 205.0 (24.3) 0.08 – 0.16
a 1=normal controls; 2=preserved; 3=deteriorated; 4=compromised; commas indicate that groups are not significantly different from one
another.
b Effect sizes presented for groups 2 versus 3 only; positive values indicate that group 2 has the higher or less pathological score; negative values
indicate that group 3 has the higher or less pathological score.
c Ns vary due to missing data.
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between the preserved and deteriorated patients on any
of the seven composite functions, and only one
significant individual score difference1.
4. Discussion
Patient subgrouping resulted in 27.5% in the
preserved group, 50% in the deteriorated group, and
22.5% in the compromised group. This distribution is
very similar to that found in the Weickert et al. (2000)
study (24.8%, 51.3%, and 23.9%, respectively), but it
differs from the Badcock et al. (2005) study (41.3%,
43.1%, and 15.6%, respectively). Sampling differences
may account for the larger preserved and smaller
compromised groups in the Badcock et al. (2005)
study because it included more outpatients and more
paranoid subtype patients than the other two studies.
Although the same criteria were used to define groups in
all three studies, they differed somewhat in the size of
estimated premorbid-current IQ differences within
groups, and in which groups differed in current FSIQ.
Sampling differences, as well as the use of different
measures to estimate premorbid and current IQ, may
have contributed to such discrepancies.
4.1. Relationship of presumed IQ trajectory to current
neuropsychological performance
By comparing subsets of individuals from the
deteriorated and preserved groups that had equivalent
(and average) current IQ, we were able to examine the
effect of presumed IQ decline on neuropsychological
function unconfounded by differences in current IQ. In
this case, both groups had very similar levels of
neuropsychological performance. There were no other
substantial demographic or clinical characteristics
between the groups that might account for the results.
If the index of decline (WRAT-R Reading minus FSIQ)
is valid, then the preserved and deteriorated groups must
have experienced very different IQ trajectories, with the
latter experiencing much greater deterioration from
premorbid ability levels than the former. Despite the
very different presumed IQ trajectories (stable vs.
declining), current neuropsychological performance
did not differ if current IQs were similar. These results
suggest that current neuropsychological strengths and
weaknesses in schizophrenia do not differ greatly as a
function of IQ trajectory up to that point (i.e., whether or
not there were declines in IQ from premorbid levels).
Rather, it appears that the more powerful association is
simply the tendency for current neuropsychological
function to covary with current IQ.
4.2. Neuropsychological performance in schizophrenia
patients with preserved IQ
The present analyses of FSIQ-matched groups
suggest that both preserved and deteriorated patients
manifested neuropsychological decline relative to their
current IQ, but, by definition, only the latter showed a
pattern consistent with presumed IQ decline from
premorbid levels. Thus, the neurocognitive compromise
of schizophrenia might leave IQ essentially unaffected
in some cases, with deficiencies restricted to other
neuropsychological functions. Paralleling the conclu-
sions of Weickert et al. (2000) and Badcock et al. (2005)
that executive function deficits are core cognitive
features of schizophrenia, the present results are
consistent with the idea that patients in the preserved
IQ subgroup manifest a kind of dysexecutive syndrome.
This is consistent with the fact that prefrontal cortical
lesions can cause significant neuropsychological deficits
Fig. 1. Neuropsychological profiles of schizophrenia patients and
controls. Solid lines/filled markers represent subgroups equated for
current IQ (total n=65 controls and 40 patients). Dashed lines/unfilled
markers represent full sample for each group (total n=92 controls and
80 patients). Preserved and compromised group profiles are shown for
the full samples only because: 1) controls and deteriorated groups were
matched to the full-sample preserved group; and 2) none of the
matched-group comparisons included the compromised group.
1 Although these differences were almost all nonsignificant, it may
be noted that the direction of differences between the preserved and
deteriorated groups did tend to differ in Table 5 versus Fig. 1. The
reason for this shift is that Table 5 shows unadjusted comparisons of
individual neuropsychological scores whereas Fig. 1 shows age-, sex-,
and parental education-adjusted comparisons of composite function
scores.
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in the absence of substantial IQ decline (Heilman and
Valenstein, 1979).
4.3. Verbal IQ–performance IQ comparisons
It was also noted that after being equated for current
IQ, the deteriorated group still had a significantly larger
VIQ–PIQ difference than the preserved group. The fact
that decline is somewhat stronger in performance rather
than verbal subtests is relatively consistent with earlier IQ
findings in schizophrenia (Heaton and Drexler, 1987;
Bilder et al., 1992), although it is possible that the larger
VIQ–PIQ differences existed premorbidly. For the most
part, Tables 3 and 5 indicate that this difference between
preserved and deteriorated patients is not related to
differential effects for specific neuropsychological func-
tions. However, after matching, the effect size for the
difference between these groups on Trails A was 0.49
(Table 5). This raises the possibility that perceptual–motor
slowing could play a role in the verbal performance-IQ
differences between these groups. On the other hand, this
suggestion is tempered by the fact that this was only 1 of
19 comparisons in Table 5, and that Badcock et al. (2005)
found no group differences on inspection time, another
processing speed measure.
4.4. Limitations
Most importantly, cross-sectional analyses do not
allow us to be certain that patients in the deteriorated
group actually experienced decline. It is possible that
large Reading-IQ discrepancies existed premorbidly.
Even if we were certain of decline, we cannot be sure
whether it began before onset, or early or late in the
course of illness. The rationale for our IQ decline index
was based, in part, on the assumption that WRAT-R
Reading is largely unaffected by schizophrenic illness.
Despite strong support for this notion (Dalby and
Williams, 1986; Goldberg et al., 1990; Kremen et al.,
1995, 1996), some patients may still experience
schizophrenia-related reading recognition impairment.
In those cases, WRAT-R Reading scores would
underestimate premorbid ability and Reading-IQ differ-
ences would be reduced; consequently, IQ decline
would be underestimated. Analogous concerns have
been raised about Reading-IQ discrepancy scores in
people with reading disability (Fletcher et al., 1992),
although in that case the nature of the problem is
reversed. That is, IQ, rather than reading, is assumed to
be relatively unaffected.
We estimated IQ from a subset of WAIS-R tests. Use
of the complete WAIS-R would have been ideal;
however, regression models derived from the subset of
participants who were administered the complete test
suggest that our estimate has a high degree of accuracy.
Differences across studies may, in part, be due to
differences in premorbid and current IQ measures. Our
measures were more similar to those used by Weickert
et al. (2000) than those used by Badcock et al. (2005). It
should also be noted that the correlation between
WRAT-R Reading and IQ in our sample was 0.73 for
controls and 0.66 for patients (Psb0.0001). Although
highly significant, these associations indicate that
WRAT-R Reading (or any other word recognition
measure) provides an imperfect estimate of IQ.
It would have been preferable to have used a structured
interview instead of the MMPI to assess controls. On the
other hand, our previous work suggests that these
participants do constitute a reasonable control group
(Faraone et al., 1995; Kremen et al., 1996); the present
results are consistent with previous results using a similar
test battery (Weickert et al., 2000), and the nature of the
control group would not affect the key comparisons
among the schizophrenia groups. Finally, there were some
significant differences in sex ratios across groups in our
study. However, these differences were not significant
among the schizophrenia patients, and the results held up
in comparisons based on composite neuropsychological
function scores that were adjusted for sex.
4.5. Implications
It is worth clarifying that our conclusion in no way
implies that the presence or absence of decline in
cognitive function in schizophrenia is inconsequential.
However, in order to make inferences about IQ decline, it
is important to rule out a simpler explanation based on IQ
differences at a single point in time. In previous work, we
looked at actual (not estimated) IQ decline in children
tested at ages 4 and 7; substantial declines predicted
increased risk for psychotic symptoms at age 23 (Kremen
et al., 1998). Large declineswould tend tomean lower IQs
at age 7, so it might just be lower IQ— not IQ decline—
that predicted later psychotic symptoms. In this instance,
IQ decline was a significant predictor even after
controlling for IQ at age 7. In contrast, we believe that
the results of the present study and the Weickert and
Badcock studies suggest that IQ decline does not add
much to current IQ as a predictor of current neuropsy-
chological performance in schizophrenia. The outcomes
may be different, but it is important to test these two
alternatives in both cases. The different neurocognitive
trajectories that individualswith schizophrenia experience
may also have implications for cognitive or vocational
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rehabilitation. For example, deteriorated intellect might
indicate a more severe illness with less ability to improve
cognitively. On the other hand, someonewith deteriorated
intellect, but similar current IQ as someonewith preserved
intellect, might have more potential for cognitive
improvement based on his or her higher level of
premorbid ability (cf. Kremen et al., 1994). Greater
decline from premorbid levels of function may also be
associated with low self-esteem, a need to experience a
sense of grieving or mourning with regard to the loss of
skills and abilities, and difficulty coming to terms with the
resulting change in one's identity. These issues may be an
important focus of psychotherapeutic as well as cognitive
rehabilitation interventions (Seidman, 1994). In the end,
helping to clarify the areas in which IQ decline may or
may not make a difference should shed some new light on
the cognitive basis of schizophrenia.
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